|
 |
| |
 |
|
|
|
|
| |
management team
|
|
 |
Stephen Aselage |
|
| |
Senior Vice President,
Global Commercial Development
Mr. Aselage joined BioMarin in July 2005 as Senior
Vice President, Global Commercial Operations. Prior
to joining BioMarin, Mr. Aselage held the position
of Executive Vice President of Global Commercial
Operations at Cell Therapeutics where he led efforts
to streamline the company's United States and European
commercial operations. Prior to Cell Therapeutics,
Mr. Aselage served as Senior Vice President of North
American Sales and Marketing for Genzyme Corporation
following Genzyme's September 2003 acquisition of
Sangstat Medical Corporation where he had worked
since February 1999. While at Sangstat, Mr. Aselage
restructured the company's sales, marketing and
medical affairs groups and led the successful effort
to make Thymoglobulin® the top selling product
in its class. From 1996 through 1999, Mr. Aselage
served as Director of Sales and Marketing at Advanced
Tissue Sciences where he established the company's
first sales and customer service groups. Earlier
in his career, Mr. Aselage held a variety of sales
and sales management positions at biotechnology
and pharmaceutical companies including Rhone-Poulenc
Rorer Pharmaceuticals (now Sanofi-Aventis), Genentech,
Inc., and Bristol Laboratories. Mr. Aselage holds
a Bachelor of Science degree in Biology from the
University of Notre Dame. |
|
| |
|
|
|
|
|
